- April 03, 2025 11:17
Gland Pharma stock live: Shares rise 3%
Gland Pharma receives approval for Acetaminophen Injection
Stock traded 3.45% positive on the NSE at ₹1,588.
- April 03, 2025 11:15
US tariffs: Pharma industry needs long-term measures to reduce US dependence, says Pharmexcil ex-DG Uday Bhaskar
Even though pharma imports from India into the US have been exempted from the levy of reciprocal tariffs by the US administration, caution and long-term measures are the need of the hour, according to R Uday Bhaskar, former director general of Pharmaceutical Exports Promotion Council (Pharmexcil).
Read more
- April 03, 2025 11:10
Pharma stocks live today: Top gainers
Top gainers of Nifty pharma stocks as at 11 am outlook
Lupin (+4.50%), Ipca Lab (+4.43%), Sun Pharma (+4.38%), Gland Pharma (+3.92%)
- April 03, 2025 10:43
US Tariffs impact on pharma sector | Pharmexcil
Pharma: Even though pharma imports from India into the US have been exempted from the levy of reciprocal tariffs by the US administration, caution and long-term measures are need of the hour, according to R Uday Bhaskar, former director general of Pharmaceutical Exports Promotion Council (Pharmexcil).
- April 03, 2025 10:20
Pharma stocks today live: Trump tariffs impact | Brokerage recommendations
Citi on Pharma stocks: Pharma sector has been excluded from tariffs announced by Trump administration. Key stocks with higher revenue mix from the US are Aurobindo (48%), Zydus (47%) and Dr Reddys (46%) (Positive)
CLSA on Pharma stocks: Pharma being exempt from US tariffs is a positive sign for Indian cos. Stocks with higher revenue mix are Aurobindo, Zydus & DrReddy’s (Positive)
- April 03, 2025 09:59
Nifty Pharma stocks today: Shares in green | Top gainers
Gland Pharma (+7.20%)
Lupin (+4.59%)
Ipca Lab (+4.52%)
Aurobindo Pharma (+4.28%)
Sun Pharma (+4.27%)
Natco Pharma (+3.79%)
- April 03, 2025 09:55
Pharma stocks live: Indian pharma stocks defy market slump on US tariffs exemption
– Reuters
Shares of Indian drugmakers surged 4% on Thursday, in contrast to the drop in the broader stock market, after U.S. President Donald Trump’s administration exempted pharmaceutical products from the list of imports hit by reciprocal tariffs.
The pharma sub-index was the only one among the 13 major sectors that was trading higher. The benchmark Nifty 50 was down 0.74%.
Trump imposed a 26% reciprocal tariff on Indian imports as part of his wider plan to impose a 10% baseline tariff on all imports from April 5, but the duties do not apply to certain goods, including pharmaceuticals.
The U.S. imports nearly a third of Indian pharma products sold overseas. India’s pharma exports to the U.S. jumped 16% to about $9 billion last fiscal year, according to data from government-backed trade body Pharmexcil.
On the day, Dr Reddy’s climbed 6% and was the top gainer on the benchmark Nifty 50 index. Gland Pharma surged 12% and was the top gainer among pharma stocks.
Cipla and Sun Pharma rose 4% each.
Reuters
- April 03, 2025 09:54
Nifty pharma stocks live: Sun Pharma, Dr Reddy’s Laboratories, Cipla lead gainers of Nifty 50 components
Top gainers on the NSE as at 9.33 am:
Sun Pharma (+5.53%), Dr Reddy’s (+5%), Cipla (+4.09%)
- April 03, 2025 09:53
US tariffs: Indian pharma heaves a sigh of relief, for now
Indian drugmakers are heaving a sigh of relief, for now, as United States President Donald Trump unveiled his “reciprocal tariff” plans.
“Pharmaceuticals have been exempted from tariffs. The decision underscores the critical role of cost-effective, life-saving generic medicines in public health, economic stability, and national security,” the Indian Pharmaceutical Alliance said on Thursday, as the full implications of the tariff plan are still being digested.
Read more
- April 03, 2025 09:52
Trump’s tariff impact: Pharma stocks in focus today.
Nifty Pharma index soared over 4% in early trade, despite equity indices opening lower due to US President Donald Trump’s latest tariff announcement.
Trump’s administration exempted pharmaceutical products from the list of imports hit by reciprocal tariffs. According to Reuters report, the US imports nearly a third of Indian pharma products sold overseas. India’s pharma exports to the U.S. jumped 16% to about $9 billion last fiscal year, according to data from government-backed trade body Pharmexcil.
Shares of Sun Pharma, Dr Reddy’s Laboratories and Cipla traded among top gainers of Nifty 50 components. All pharmaceutical stocks traded in green.
